APA
Dai J., Niu K., Wang B., Li Y., Xia C., Tao K. & Dai J. (20190708). [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. : Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
Chicago
Dai Jimin, Niu Kunwei, Wang Bo, Li Yijie, Xia Congcong, Tao Kaishan and Dai Jingyao. 20190708. [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. : Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
Harvard
Dai J., Niu K., Wang B., Li Y., Xia C., Tao K. and Dai J. (20190708). [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. : Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
MLA
Dai Jimin, Niu Kunwei, Wang Bo, Li Yijie, Xia Congcong, Tao Kaishan and Dai Jingyao. [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. : Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 20190708.